Navigation Links
China Genetic Engineering Drug Industry Report, 2011-2012
Date:7/16/2012

NEW YORK, July 16, 2012 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

China Genetic Engineering Drug Industry Report, 2011-2012

http://www.reportlinker.com/p0934677/China-Genetic-Engineering-Drug-Industry-Report-2011-2012.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Biopharma

China gets a late start in developing genetic engineering drug industry, but has achieved leapfrog advance. At present, China has at least one hundred enterprises involved in genetic engineering drugs. In recent years, the compound growth rate of genetic engineering drug market in China is as high as 49%, with an average gross margin of more than 80%. However, the technology strength and efficacy of locally produced genetic engineering drugs are relatively weak. In particular, the pegylated recombinant human granulocyte colony stimulating factor (PEG-rhG-CSF) for injection of CSPC Pharmaceutical Group Limited that approved for marketing in March 2012 is the only homemade long-acting protein product. Still, due to the impetus of huge market capacity as well as a package of preferential policies, many domestic enterprises, including GeneScience Pharmaceuticals, Amoytop and Anhui Anke Biotechnology, are accelerating the industrialized research of long-acting protein drugs.

Monoclonal antibody is one of the most promising genetic engineering drugs. As of May 2012, SFDA approved the marketing of a total of 18 monoclonal antibody drugs. Among these drugs, nearly 60% are foreign brands including Roche, Merck and Novartis with the combined sales accounting for three fourths of the Chinese monoclonal antibody drug market. However, with the marketing of monoclonal antibody drugs made by companies such as Shanghai CP G
'/>"/>

SOURCE Reportlinker
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Diagnostic Devices Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2018
2. Ampio Advances NCE001 Cancer Drug into Preclinical Development Following Successful Recent Financing and the Granting of Patents in USA, Canada, Europe and China
3. China Botanic Attends 2012 Trade Fair
4. The 2nd Pharma Logistics China 2012 to be Held in Shanghai on 21-22 August
5. China Pharmaceuticals and Healthcare Report Q3 2012
6. China Botanics Siberian Ginseng Extract Recognized as Safe Medicine
7. Biosimilars in Emerging Economies - Advanced Recombinant Technology Platforms and Low Cost Manufacturing Put India and China at a Strategic Advantage in Biosimilar Production
8. Diabetes Care Devices in Emerging Countries (China, India, Brazil) to 2017 - Greater Awareness is Increasing Demand for Self-Monitoring of Blood Glucose (SMBG) in the Home Care Segment
9. China ENT Devices Market Outlook to 2018 - Diagnostic Devices, Hearing Aid Devices, Hearing Implants and Others
10. The Pharmaceutical Market: China
11. China Biologic Receives SFDA Manufacturing Approval Certificate for Human Coagulation Factor VIII
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2015)... , Feb. 27, 2015 Roughly three-quarters ... very confident substituting an interchangeable biosimilar for its ... the same nonproprietary name, according to a survey ... (AMCP,s) Journal of Managed Care & Specialty ... 25 percent of pharmacists would feel as confident ...
(Date:2/27/2015)... Feb. 27, 2015  Pomerantz LLP is investigating claims ... or the "Company") (NASDAQ: VTAE ).  Such ... at rswilloughby@pomlaw.com or 888-476-6529, ext. 237. ... of its officers and/or directors have violated Sections 10(b) ... On February 27, 2015, the Company ...
(Date:2/27/2015)... February 27, 2015 ... dell,innovativo sistema di monitoraggio dell,infarto congestizio (CHF - ...     Vectorious ... nuovo sistema per il monitoraggio cardiaco destinato a ... oggi di aver concluso una raccolta di finanziamenti ...
Breaking Medicine Technology:Survey Published in AMCP's JMCP Finds Pharmacists Are Most Confident Substituting Interchangeable Biosimilars for Brand Biologics When Products Share Nonproprietary Name 2SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Vitae Pharmaceuticals, Inc. - VTAE 2Vectorious Medical Technologies completa una raccolta di 5 milioni di dollari 2
... FREMONT, Calif., Nov. 19 Quark Pharmaceuticals, Inc., the leader ... its siRNA R&D platform based programs have met clinical development ... a new IND opened for ocular neuroprotection drug candidate QPI ... has completed enrollment in a Phase 2 study of PF-4523655 ...
... Nov. 19 Radiall and Integral Process will collaborate in ... agreement to confirm this new alliance. , Radiall has a ... time, the company has established relationships with major players in ... , Integral Process is a key supplier of interconnect ...
Cached Medicine Technology:Quark Reports Progress of siRNA Clinical Programs; 300 Patients Dosed With Quark Pharmaceuticals' siRNA Drugs In Multiple Fully Enrolled Clinical Trials 2Quark Reports Progress of siRNA Clinical Programs; 300 Patients Dosed With Quark Pharmaceuticals' siRNA Drugs In Multiple Fully Enrolled Clinical Trials 3Quark Reports Progress of siRNA Clinical Programs; 300 Patients Dosed With Quark Pharmaceuticals' siRNA Drugs In Multiple Fully Enrolled Clinical Trials 4Radiall and Integral Process Sign Agreement 2
(Date:3/1/2015)... Indiana (PRWEB) March 01, 2015 ... statewide Network Service Provider, announces NewWays Networking, LLC ... “By working with IFN, NewWays is well ... meet client’s demand for Internet bandwidth in rural ... , According to Cory Childs IFN Enterprise ...
(Date:2/28/2015)... Malaysia (PRWEB) February 28, 2015 The ... all across Malaysia into one platform and gears towards ... , A series of group talks in smaller ... like Nation Building, Education, Personal Development, Leadership, Entrepreneurship, Healthcare, ... and raise awareness of Malaysian youths. , ...
(Date:2/28/2015)... 2015 With their commitment to achieving ... an additional exercise to their already robust library of ... most commonly known as, is often performed on a ... executed in a relatively safe manner and can be ... The full description of “Rope Pulls” is located in ...
(Date:2/28/2015)... February 28, 2015 Vancouver personal injury lawyers ... claims are affected by time limits. They stated that in ... person’s claim or even nullify it. Many a time, delays ... a client’s rights under BC law. As a result, experts ... by accidents should consult a personal injury lawyer in order ...
(Date:2/28/2015)... Pioneer Millworks reclaimed USA wood will be ... Materials Show, an annual, premier sustainable building event in ... top manufacturers of the latest building products, services and ... and manufactured by Pioneer Millworks from their Oregon and ... restaurants, hotels, retailers, and corporate offices. Nichibi Global ...
Breaking Medicine News(10 mins):Health News:NewWays Networking Selects Indiana Fiber Network, LLC as Fiber Transport Provider 2Health News:My Mobile University Appointed Learning Partner for the Upcoming MCA’S First Youth Empowerment Conference Held in Malaysia on March 28, 2015 2Health News:My Mobile University Appointed Learning Partner for the Upcoming MCA’S First Youth Empowerment Conference Held in Malaysia on March 28, 2015 3Health News:My Mobile University Appointed Learning Partner for the Upcoming MCA’S First Youth Empowerment Conference Held in Malaysia on March 28, 2015 4Health News:Jiwa Law Corporation Recently Announced That Time Delays May Weaken Personal Injury Claims 2Health News:US Reclaimed Wood from Pioneer Millworks to be Featured at Architecture & Construction Materials Show in Tokyo. 2
... data from previously completed withdrawal to monotherapy studies for ... studies, obviating the need for placebo/pseudo-placebo trials to demonstrate ... this study are now available online in Epilepsia ... the International League Against Epilepsy. According to a ...
... is available in French . Montreal, ... Heart Institute (MHI) has shown unexpectedly that living with children ... with 756 participants and led by Dr. Simon L. Bacon, ... the study assessed the impact of social networks on exercise, ...
... lives of infants and children with developmental disabilities will ... Developmental Disabilities Research Center (WUIDDRC). The center, established ... National Institutes of Health (NIH), will focus on research ... emphasis will be placed on clinical and translational research ...
... 2010 - Janice Morse, RN, PhD, FAAN, a professor ... inducted into the newly created Sigma Theta Tau International ... researchers who have achieved long-term, broad national and/or international ... research has impacted the profession and the people it ...
... the skin cancer melanoma appear different in Florida than ,from ... non-Hispanic black women but lower rates among Hispanic women, according ... of Dermatology, one of the JAMA/Archives journals. "In ... than that of any other cancer," the authors write as ...
... , MONDAY, July 19 (HealthDay News) -- Children conceived using ... than do children who were conceived naturally, new research shows. ... increased by 42 percent for Swedish youngsters conceived with IVF, ... "We found a roughly 50 percent increased risk for cancer ...
Cached Medicine News:Health News:FDA accepts historical controls for epilepsy monotherapy studies 2Health News:FDA accepts historical controls for epilepsy monotherapy studies 3Health News:Concordia researcher leads study that finds kids reduce physical activity for heart patients 2Health News:Developmental disabilities center established at Washington University 2Health News:U of U's Janice Morse inducted into International Nurse Researcher Hall of Fame 2Health News:Melanoma rates among minorities in Florida differ from national trends 2Health News:Study Suggests Higher Cancer Rate Among IVF Babies 2Health News:Study Suggests Higher Cancer Rate Among IVF Babies 3
... with the MAMMOTOME® HH (Hand ... invasive procedure using ultrasound imaging ... images to locate breast abnormalities, ... and map the area you ...
... A biopsy with the MAMMOTOME® ... effective, minimally invasive procedure using ... management.,Using computer-generated images to locate ... accurately pinpoint and map the ...
... occlusive wrap than VICRYL knitted mesh. Especially ... be contained. Predictable absorption. Polyglactin 910 has ... nonpyrogenic. ,VICRYL (polyglactin 910) woven mesh is ... glycolide and lactide, derived respectively from glycolic ...
... Line Reinforcement Material is a safe, ... air leaks and as such, the ... biocompatible, ePTFE material requires no pretreatment ... load and fire and the material's ...
Medicine Products: